Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine for Cisplatin-Induced Nephrotoxicity
NCT07156786Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine, Universitas Indonesia
- Start
- Sep 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of acetylcysteine in acute kidney injury (AKI), sponsored by Faculty of Medicine, Universitas Indonesia. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07156786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07156786.